SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
India
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Bafna Pharmaceuticals Ltd.

Main Activities: Pharmaceutical and Medicine Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Bafna Pharmaceuticals Ltd.

Legal Address
Bafna Towers,, New No. 68, Old No. 299,    , Thambu Chetty Street; Chennai; Tamil Nadu; 600001
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24294TN1995PLC030698
ISIN CODE : INE878I01014
Financial Auditors: Abhay Jain & Co. (2013)
Incorporation Date: January 1, 1995
Total Employees: 358

Tel: 25267517/ 42677555/

Company Description

Bafna Pharmaceuticals Limited engages in the manufacture and sale of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including anti-bacterials, anti-pyretics, antconvulsants, anxiolytics, pain management, anthelmintics, anti-fungal, appetite stimulants, antidiarrhoeals, antiemetics, hypnotics, antacids and anti-ulcerants, vitamin and dietary preparations, cough and cold preparations, anti-asthmatics, calcium preparations, anti-hypertensives,
More

Key Executives

Bafna Mahaveer Chand Chairman & Managing Director
Paras Bafna Whole Time Director
K Premnatha Company Secretary
Kamlesh Kumar Ind. Non-Executive Director
M Sridhar Manager - Finance & Accounts
More
SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
2014 Q3C
(non-cons)
2014 H1
(non-cons)
Non-Audited Non-Audited
Unit Tens of Millions) Tens of Millions
Balance Sheet

Shareholders Equity

XXX

XXX

* All the accounts are in INR.
Income Statement

Total Operating Revenue

XXX

XXX

Operational Profit (Loss)

XXX

XXX

Net Profit (Loss)

XXX

XXX

* All the accounts are in INR.
Ratios
Profitability Ratios

Return on Sales (ROS)

XXX

XXX

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

XXX

XXX

EBITDA

XXX

XXX

Market ratios

Market cap/Shareholder equity

XXX

XXX

Trend Ratios

Revenue Trend

XXX

XXX

Operating Income Trend

XXX

XXX